Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis
Clinical trial NCT04024891 · COMPLETED
Trial details
- NCT number
- NCT04024891
- Sponsor
- Ocuphire Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2019-09-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.